Drug Co. Aceragen OK'd For Chancery-Overseen Liquidation
Biopharmaceutical company Aceragen Inc. secured a Delaware Court of Chancery go-ahead for its bankruptcy-alternative liquidation under a court-supervised assignment for the benefit of creditors in favor of a NovaQuest Capital Management...To view the full article, register now.
Already a subscriber? Click here to view full article